Pharma is poised to make billions from COVID-19 vaccine booster shots many aren’t okay with that

Advertisements
Read Time:42 Second

COVID-19 vaccine boosters are coming and many who are already skeptical of a medical industry reaping profits from a national disaster have more reasons to question those at the top. While vaccines do work and have offered plentiful protections so far to the inoculated, it remains to be seen how much more good pharma will do with billions in profit from said boosters.

According to Newser, one section of Pharma (namely Pfizer) is expected to make upwards of $26B in sales from its vaccines and boosters whilst Moderna is expected to make upwards of $14B.

Moderna has no other reported product in the market outside of its vaccines and pending booster shots that it hopes to get endorsed by governments. In Britain, the government is expected to actually recommend the opposite Pfizer being the first choice Moderna being the second.

Advertisements

About Post Author

Guest Columns

Happy
Happy
%
Sad
Sad
%
Excited
Excited
%
Sleepy
Sleepy
%
Angry
Angry
%
Surprise
Surprise
%
See also  As containment becomes impossible, South Africa announces it will cease following guidelines and isolation rules with exceptions

Leave a Reply

Previous post Kelly Price ‘s sister maintains that she is STILL missing despite reports otherwise
Next post Shocking allegations of state sponsored assassination attempts on Julian Assange surface against the U.S: Reports
Cookie Consent with Real Cookie Banner Skip to content